株探米国株
日本語 英語
エドガーで原本を確認する
false000000209800000020982024-10-182024-10-18

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (date of earliest event reported): October 18, 2024

 

ACME UNITED CORPORATION

(Exact name of registrant as specified in its charter)

 

 

Connecticut

001-07698

06-0236700

(State or other jurisdiction

of incorporation or organization)

(Commission file number)

(I.R.S. Employer

Identification No.)

1 Waterview Dr, Shelton, Connecticut

 

06484

(Address of principal executive offices)

 

(Zip Code)

Registrant’s telephone number, including area code: (203) 254-6060

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Common Stock, $2.50 par value per share

 

ACU

 

NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

On October 18, 2024, Acme United Corporation (the “Company”) issued a press release announcing its financial results for the quarter ended September 30, 2024. A copy of the press release is attached as Exhibit 99.1 to this current report.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.

(c) Exhibits

 

Exhibit

Number

Description

99.1

Press release dated October 18, 2024.

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

ACME UNITED CORPORATION

 

By

/s/ Walter C. Johnsen

Walter C. Johnsen

Chairman and

Chief Executive Officer

Dated: October 18, 2024

By

/s/ Paul G. Driscoll

Paul G. Driscoll

Vice President and

Chief Financial Officer

Dated: October 18, 2024

 

 


EX-99.1 2 acu-ex99_1.htm EX-99.1 EX-99.1

 

 

ACME UNITED CORPORATION NEWS RELEASE

CONTACT: Paul G. Driscoll Acme United Corporation 1 Waterview Drive Shelton, CT 06484

Phone: (203) 254-6060

 

FOR IMMEDIATE RELEASE October 18, 2024

 

 

ACME UNITED REPORTS 3% INCREASE IN NET INCOME FOR

THIRD QUARTER OF 2024

 

SHELTON, CT – October 18, 2024 – Acme United Corporation (NYSE American: ACU) today announced that net sales for the quarter ended September 30, 2024 were $48.2 million compared to $50.4 million in the third quarter of 2023, a decrease of 4%. Excluding the impact of the Camillus and Cuda hunting and fishing product lines sold on November 1, 2023, net sales for the third quarter of 2024 increased 4% compared to the third quarter of 2023. Net sales for the nine months ended September 30, 2024 were $148.5 million compared to $149.6 million in the same period in 2023, a decrease of 1%. Excluding Camillus and Cuda, net sales for the nine months increased 5% compared to the same period in 2023.

 

Net income was $2.23 million, or $0.54 per diluted share, for the quarter ended September 30, 2024 compared to $2.15 million, or $0.58 per diluted share, for the same period in 2023, an increase of 3% in net income and a decrease of 7% in diluted earnings per share. Net income for the nine months ended September 30, 2024 was $8.31 million, or $2.03 per diluted share, compared to $6.59 million, or $1.83 per diluted share, for the same period in 2023, an increase of 26% in net income and 11% in diluted earnings per share.

 

Chairman and CEO Walter C. Johnsen said, “After a strong performance in the first half of 2024, sales of first aid products in the U.S. were soft in the third quarter due to customer timing and market conditions. Sales of our Westcott cutting tools and DMT sharpeners continued to be strong in the quarter, with increased placement in large mass market accounts.”

 

“During the quarter, we introduced the latest generation of industrial first aid kits with patented automatic replenishment capabilities. The use and expiration of components in the kits are now monitored in real time, allowing the customer to order replacements automatically.

1

 


 

First aid units with these capabilities facilitate compliance with OSHA, ANSI, and other regulations.”

 

For the three months ended September 30, 2024, net sales in the U.S. segment decreased 6% compared to the same period in 2023. Excluding Camillus and Cuda, net sales for the third quarter of 2024 increased 3% compared to the third quarter of 2023. For the nine months ended September 30, 2024, net sales in the U.S. segment decreased 1% compared to the same period in 2023. Excluding Camillus and Cuda, net sales for the nine months increased 5% compared to the same period in 2023. The sales increase for the nine-month period was due to market share gains across multiple product lines.

 

European net sales for the three months ended September 30, 2024 increased 10% in both U.S. dollars and local currency compared to the third quarter of 2023. Excluding Camillus and Cuda, net sales for the third quarter of 2024 increased 15% compared to the third quarter of 2023. Net sales for the nine months ended September 30, 2024 increased 6% in both U.S. dollars and local currency compared to the first nine months of 2023. Excluding Camillus and Cuda, net sales for the nine months increased 10% compared to the same period in 2023. The sales increase for both periods was due to market share gains in the office channel.

Net sales in Canada for the three months ended September 30, 2024 decreased 1% in U.S. dollars but increased 2% in local currency compared to the same period in 2023. Excluding Camillus and Cuda, net sales for the third quarter of 2024 increased 6% compared to the third quarter of 2023. Net sales for the nine months ended September 30, 2024 decreased 5% in U.S. dollars and 4% in local currency compared to the first nine months of 2023. Excluding Camillus and Cuda, net sales for the nine months were constant compared to the same period in 2023. Sales of first aid products were strong, however sales of school and office products continued to be adversely impacted by a soft economy.

 

Gross margin was 38.5% in the three months ended September 30, 2024 versus 38.7% in the comparable period last year. Gross margin was 39.4% for the nine-month period ended September 30, 2024 compared to 37.3% for the same period in 2023. The increase in the nine-month period was primarily due to productivity improvements in the Company’s manufacturing and distribution facilities.

2

 


 

 

The Company’s bank debt less cash as of September 30, 2024 was $26.7 million compared to $38.2 million as of September 30, 2023. During the twelve-month period ended September 30, 2024, the Company paid approximately $6.1 million for the acquisition of the assets of Elite First Aid Inc., distributed $2.2 million in dividends on its common stock and generated approximately $6.2 million in free cash flow. Additionally, the Company realized net proceeds from the sale of the Camillus and Cuda product lines of approximately $13.0 million.

 

Conference Call and Webcast Information

Acme United will hold a conference call to discuss its quarterly results, which will be broadcast on Friday, October 18, 2024, at 12:00 p.m. ET. To listen or participate in a question and answer session, dial 877-407-0784. International callers may dial 201-689-8560. The confirmation code is 13748799. You may access the live webcast of the conference call through the Investor Relations section of the Company’s website, www.acmeunited.com. A replay may be accessed under Investor Relations, Audio Archives.

 

About Acme United

ACME UNITED CORPORATION is a leading worldwide supplier of innovative safety solutions and cutting technology to the school, home, office, hardware, sporting goods and industrial markets. Its leading brands include First Aid Only®, First Aid Central®, PhysiciansCare®, Pac-Kit®, Spill Magic®, Westcott®, Clauss®, DMT®, Med-Nap and Elite First Aid. For more information, visit www.acmeunited.com.

 

Forward Looking Statements

The Company may from time to time make written or oral “forward-looking statements” including statements contained in this report and in other communications by the Company, which are made in good faith pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on our beliefs as well as assumptions made by and information currently available to us. When used in this document, words like “may,” “might,” “will,” “except,” “anticipate,” “believe,”

3

 


 

“potential,” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from our current expectations.

 

Forward-looking statements in this report, including without limitation, statements related to the Company’s plans, strategies, objectives, expectations, intentions and adequacy of resources, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties that may impact the Company’s business, operations and financial results.

 

These risks and uncertainties include, without limitation, the following: (i) changes in the Company’s plans, strategies, objectives, expectations and intentions, which may be made at any time at the discretion of the Company; (ii) the impact of uncertainties in global economic conditions, including the impact on the Company’s suppliers and customers; (iii) the continuing adverse impact of inflation, including product costs, and interest rates; (iv) potential adverse effects on the Company, its customers, and suppliers resulting from the conflicts in Ukraine and the Middle East; (v) additional disruptions in the Company’s supply chains, whether caused by pandemics, natural disasters, including trucker shortages, strikes, port closures or otherwise; (vi) labor related costs the Company has and may continue to incur, including costs of acquiring and training new employees and rising wages and benefits; (vii) currency; (viii) the Company’s ability to effectively manage its inventory in a rapidly changing business environment; (ix) changes in client needs and consumer spending habits; (x) the impact of competition; (xi) the impact of technological changes including, specifically, the growth of online marketing and sales activity; (xii) the Company’s ability to manage its growth effectively, including its ability to successfully integrate any business it might acquire; (xiii) international trade policies and their impact on demand for our products and our competitive position, including the imposition of new tariffs or changes in existing tariff rates; and (xiv) other risks and uncertainties indicated from time to time in the Company’s filings with the Securities and Exchange Commission.

# # #

 

 

 

4

 


 

ACME UNITED CORPORATION

 

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

 

THIRD QUARTER REPORT 2024

 

(Unaudited)

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

Three Months Ended

 

Amounts in 000's except per share data

 

September 30, 2024

 

 

September 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

48,166

 

 

$

50,384

 

Cost of goods sold

 

 

29,602

 

 

 

30,881

 

Gross profit

 

 

18,564

 

 

 

19,503

 

Selling, general, and administrative expenses

 

 

15,638

 

 

 

15,846

 

Operating income

 

 

2,926

 

 

 

3,657

 

Interest expense

 

 

568

 

 

 

816

 

Interest income

 

 

(33

)

 

 

(32

)

Interest expense, net

 

 

535

 

 

 

784

 

Other (income) expense, net

 

 

(17

)

 

 

55

 

Income before income tax expense

 

 

2,408

 

 

 

2,818

 

Income tax expense

 

 

182

 

 

 

666

 

Net income

 

$

2,226

 

 

$

2,152

 

 

 

 

 

 

 

 

Shares outstanding - Basic

 

 

3,726

 

 

 

3,578

 

Shares outstanding - Diluted

 

 

4,104

 

 

 

3,721

 

 

 

 

 

 

 

 

Earnings per share - Basic

 

$

0.60

 

 

$

0.60

 

Earnings per share - Diluted

 

 

0.54

 

 

 

0.58

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5

 


 

ACME UNITED CORPORATION

 

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

 

THIRD QUARTER REPORT 2024 (cont.)

 

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended

 

 

Nine Months Ended

 

Amounts in 000's except per share data

 

September 30, 2024

 

 

September 30, 2023

 

 

 

 

 

 

 

 

Net sales

 

$

148,547

 

 

$

149,559

 

Cost of goods sold

 

 

89,960

 

 

 

93,752

 

Gross profit

 

 

58,587

 

 

 

55,807

 

Selling, general, and administrative expenses

 

 

46,728

 

 

 

44,711

 

Operating income

 

 

11,859

 

 

 

11,096

 

Interest expense

 

 

1,622

 

 

 

2,595

 

Interest income

 

 

(105

)

 

 

(78

)

Interest expense, net

 

 

1,517

 

 

 

2,517

 

Other (income) expense, net

 

 

(90

)

 

 

9

 

Income before income tax expense

 

 

10,432

 

 

 

8,570

 

Income tax expense

 

 

2,117

 

 

 

1,984

 

Net income

 

$

8,315

 

 

$

6,586

 

 

 

 

 

 

 

 

Shares outstanding - Basic

 

 

3,686

 

 

 

3,558

 

Shares outstanding - Diluted

 

 

4,087

 

 

 

3,596

 

 

 

 

 

 

 

 

Earnings per share - Basic

 

$

2.26

 

 

$

1.85

 

Earnings per share - Diluted

 

 

2.03

 

 

 

1.83

 

 

 

 

 

 

 

6

 


 

ACME UNITED CORPORATION

 

CONDENSED CONSOLIDATED BALANCE SHEETS

 

THIRD QUARTER REPORT 2024

 

(Unaudited)

 

 

 

Amounts in 000's

 

September 30, 2024

 

 

September 30, 2023

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

5,702

 

 

$

5,567

 

Accounts receivable, net

 

 

31,349

 

 

 

33,855

 

Inventories

 

 

55,990

 

 

 

54,575

 

Prepaid expenses and other current assets

 

 

5,733

 

 

 

3,779

 

Restricted cash

 

 

-

 

 

 

750

 

Total current assets

 

 

98,774

 

 

 

98,526

 

 

 

 

 

 

 

 

Property, plant and equipment, net

 

 

30,892

 

 

 

27,708

 

Operating lease right of use asset

 

 

4,808

 

 

 

2,300

 

Intangible assets, less accumulated amortization

 

 

22,810

 

 

 

19,546

 

Goodwill

 

 

8,189

 

 

 

8,189

 

Total assets

 

$

165,473

 

 

$

156,269

 

 

 

 

 

 

 

 

Liabilities and stockholders' equity:

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

7,008

 

 

$

9,976

 

Operating lease liability - short term

 

 

1,550

 

 

 

1,165

 

Mortgage payable - short term

 

 

433

 

 

 

415

 

Other accrued liabilities

 

 

13,403

 

 

 

13,873

 

Total current liabilities

 

 

22,394

 

 

 

25,429

 

Long term debt

 

 

22,018

 

 

 

32,934

 

Mortgage payable - long term

 

 

9,970

 

 

 

10,393

 

Operating lease liability - long term

 

 

3,357

 

 

 

1,279

 

Other non-current liabilities

 

 

1,417

 

 

 

328

 

Total liabilities

 

 

59,156

 

 

 

70,363

 

Total stockholders' equity

 

 

106,317

 

 

 

85,906

 

Total liabilities and stockholders' equity

 

$

165,473

 

 

$

156,269

 

 

7